Buy One Get One free -Llimited Time Offer X
Manicarb 300 Tablet SR is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Mania. Secondary and off-label uses of Manicarb 300 Tablet SR have also been mentioned below.
The optimal dosage of Manicarb 300 Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Manicarb 300 Tablet SR can also lead to other problems, which have been listed below. Normally, these side effects of Manicarb 300 Tablet SR are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Manicarb 300 Tablet SR's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Manicarb 300 Tablet SR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Manicarb 300 Tablet SR related warnings section.
Manicarb 300 Tablet SR is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Diarrhea (Loose Motions), Heart Disease are examples of such conditions.
Drug reaction of Manicarb 300 Tablet SR with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Manicarb 300 Tablet SR is not safe while driving, and is is not addictive in nature.
Manicarb 300 Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Manicarb 300 Tablet SR safe for pregnant women?
Manicarb shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Manicarb 300 Tablet SR safe during breastfeeding?
Manicarb may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Manicarb 300 Tablet SR on the Kidneys?
Manicarb rarely harms the kidneys.
What is the effect of Manicarb 300 Tablet SR on the Liver?
Manicarb is not harmful for the liver.
What is the effect of Manicarb 300 Tablet SR on the Heart?
Manicarb may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Manicarb 300 Tablet SR unless your doctor advises you to do so -
Is this Manicarb 300 Tablet SR habit forming or addictive?
No, there is no any evidence that Manicarb 300 Tablet SR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Manicarb 300 Tablet SR you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Manicarb 300 Tablet SR only on doctor's advice.
Is it able to treat mental disorders?
Yes, Manicarb 300 Tablet SR is useful in treating mental disorders.
Interaction between Food and Manicarb 300 Tablet SR
Taking Manicarb 300 Tablet SR with food does not harm your health.
Interaction between Alcohol and Manicarb 300 Tablet SR
Taking alcohol with Manicarb 300 Tablet SR can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lithium
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 447-450
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 783-784